Immune System & Allergies terms

A plasmid DNA cancer vaccine encoding the intracellular domain (ICD) of the HER-2/neu proto-oncogene.

A cancer vaccine consisting of the DNA plasmid pNGVL4a-A encoding calreticulin (CRT) linked to a detox form of human papillomavirus (HPV) type 16 E7 antigen, with potential immunomodulating and…

An antigen-specific DNA cancer vaccine consisting of the coding sequences of a signal peptide (pNGVL4a-Sig), a detox form of the human papillomavirus type 16 (HPV-16) antigen E7, and the heat shock…

(Other name for: pneumococcal polyvalent vaccine)

A substance that is being studied in the treatment of cancer and for its ability to stimulate the immune system.

A poly-Toll-like receptor (TLR) agonist polyantigenic vaccine containing heat killed Mycobacterium indicus pranii (Mycobacterium w or Mw) with potential immunostimulating and antineoplastic…

(Other name for: therapeutic immune globulin)

A type of immune cell that has granules (small particles) with enzymes that are released during infections, allergic reactions, and asthma.

A multivalent cancer vaccine comprised of the five tumor-associated antigens (TAAs) globo H, GM2 ganglioside, Tn-MUC1, TF, and sTn conjugated with the immunoadjuvant keyhole limpet hemocyanin (KLH)…

A cancer vaccine consisting of whole irradiated heterologous melanoma cells which express multiple melanoma-related antigens.

A condition in which a group of B-cells grow out of control after an organ transplant in patients with weakened immune systems.

A cancer vaccine containing PR1, a 9 amino-acid human leukocyte antigen (HLA)-A2 restricted peptide derived from proteinase 3, with potential immunotherapeutic activity.

A monoclonal antibody that is being studied in the detection and treatment of cancer.

A cell-based vaccine derived from prostate cancer with potential immunopotentiating and antineoplastic activities.

A protein made by the prostate gland and found in the blood.

A blood test that measures the level of prostate-specific antigen (PSA), a substance produced by the prostate and some other tissues in the body.

(Other name for: recombinant vaccinia prostate-specific antigen vaccine)

A brief rise and then fall in the blood level of PSA (prostate-specific antigen) that occurs in some patients 1-3 years after receiving radiation treatment for prostate cancer.

A rise in the blood level of PSA (prostate-specific antigen) in prostate cancer patients after treatment with surgery or radiation.

An autologous dendritic cell vaccine with potential immunostimulatory activity.